Literature DB >> 17473695

Prognostic significance of the MUC1 and MUC4 expressions in thyroid papillary carcinoma.

Seung-Kuk Baek1, Jeong-Soo Woo, Soon-Young Kwon, Sang-Hag Lee, Yang-Seok Chae, Kwang-Yoon Jung.   

Abstract

OBJECTIVES: The aim of the present study was to examine the expressions of mucin genes MUC1 and MUC4 and to evaluate the difference of their expressions in normal thyroid tissue, follicular adenoma, and papillary carcinoma. Furthermore, we aimed to estimate their prognostic significance in papillary carcinoma.
METHODS: We performed semiquantitative reverse-transcription polymerase chain reaction for determining the MUC1 and MUC4 mRNA expressions, and immunohistochemical staining was performed to determine the MUC1 and MUC4 protein expressions in 22 normal thyroid tissues, 22 follicular adenomas, and 15 papillary carcinomas. The semiquantitative scoring of the immunohistochemical staining was compared with the prognostic factors for thyroid carcinoma to evaluate the prognostic significance in 87 papillary carcinoma patients.
RESULTS: The MUC1 mRNA of the papillary carcinoma tissue showed an increased expression level compared with the other tissues. However, the expression level of MUC4 mRNA was weak in all the specimens, and this was not significantly different among the three groups. MUC1 immunoreactivity was more intense in papillary carcinoma but not in the other tissues. MUC4 was not expressed in all thyroid tissues. The expression of MUC1 was significantly associated with tumor size, extrathyroidal spread, and TNM stage (P < .05).
CONCLUSIONS: Up-regulation of MUC1 may play a more important role than that of MUC4 in the development of thyroid papillary carcinoma, and it may have some significance as a prognostic factor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17473695     DOI: 10.1097/MLG.0b013e31803d1720

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

1.  Muc-1 expression may help characterize thyroid nodules but does not predict patients' outcome.

Authors:  Elaine Cristina Morari; Joyce Rosário Silva; Ana Carolina Trindade Guilhen; Lucas Leite Cunha; Marjory Alana Marcello; Fernando Augusto Soares; José Vassallo; Laura Sterian Ward
Journal:  Endocr Pathol       Date:  2010-12       Impact factor: 3.943

2.  Expression of MUC1 and CD176 (Thomsen-Friedenreich antigen) in papillary thyroid carcinomas.

Authors:  Xiang-xiang Zhan; Bing Zhao; Chang Diao; Yi Cao; Ruo-chuan Cheng
Journal:  Endocr Pathol       Date:  2015-03       Impact factor: 3.943

3.  Mucin gene 19 (MUC19) expression and response to inflammatory cytokines in middle ear epithelium.

Authors:  Joseph E Kerschner; Pawjai Khampang; Christy B Erbe; Alexander Kolker; Joseph A Cioffi
Journal:  Glycoconj J       Date:  2009-12       Impact factor: 2.916

4.  Follicular adenoma with extensive extracellular mucin deposition: report on two cases.

Authors:  Na Rae Kim; Hyun Yee Cho; Sergio Piña-Oviedo; Gustavo De La Roza; Young Don Lee; Jae Y Ro
Journal:  Clin Med Insights Case Rep       Date:  2012-11-26

5.  Prognostic and clinicopathological significance of MUC expression in head and neck cancer: a systematic review and meta-analysis.

Authors:  Hao Lu; Dan Liang; Yun Zhu; Wanlin Xu; Kaihua Zhou; Limin Liu; Shengwen Liu; Wenjun Yang
Journal:  Oncotarget       Date:  2017-07-27

6.  Promotion of tumor progression and cancer stemness by MUC15 in thyroid cancer via the GPCR/ERK and integrin-FAK signaling pathways.

Authors:  Cheolwon Choi; Nguyen Thi Thao Tran; Trinh Van Ngu; Sae Woong Park; Min Suk Song; Sung Hyun Kim; Yun-Ui Bae; Penchatr Diskul Na Ayudthaya; Javaria Munir; Eunbit Kim; Moo-Jun Baek; Sujung Song; Seongho Ryu; Kee-Hyun Nam
Journal:  Oncogenesis       Date:  2018-11-12       Impact factor: 7.485

7.  MUC4 and MUC1 expression in adenocarcinoma of the stomach correlates with vessel invasion and lymph node metastasis: an immunohistochemical study of early gastric cancer.

Authors:  Yukihiro Tamura; Michiyo Higashi; Sho Kitamoto; Seiya Yokoyama; Masahiko Osako; Michiko Horinouchi; Takeshi Shimizu; Mineo Tabata; Surinder K Batra; Masamichi Goto; Suguru Yonezawa
Journal:  PLoS One       Date:  2012-11-13       Impact factor: 3.240

8.  Targeting interleukin-17 receptor B enhances gemcitabine sensitivity through downregulation of mucins in pancreatic cancer.

Authors:  Lung-Hung Tsai; Kai-Wen Hsu; Cheng-Ming Chiang; Hsiu-Ju Yang; Yu-Huei Liu; Shun-Fa Yang; Pei-Hua Peng; Wei-Chung Cheng; Heng-Hsiung Wu
Journal:  Sci Rep       Date:  2020-10-20       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.